InstaPill® From Tenshi Kaizen
We are a globally recognized contract development and manufacturing organization specializing in orally disintegrating tablets using our proprietary InstaPill® technology platform. Our facility in Bengaluru, India, houses highly qualified and experienced pharma professionals who have successfully developed and manufactured products registered and distributed in over 50 countries.
We remain at the forefront of this platform technology by constantly providing cutting edge solutions to our client programs. Our commitment to innovation and compliance with regulatory standards including approvals from the USFDA, EU, TGA and other regulatory bodies ensures that we meet the latest requirements. To meet the ever increasing demand of our existing and future clients, we have a capacity of 200 million tablets which is set to scale up to 300 million tablets.
We don’t just manufacture. We enable. From early formulation through regulatory approvals and commercial supply, our integrated services are designed to reduce time to market enhance product performance and ensure consistent quality at scale.
Our Vision
We envision a future where we continuously push the boundaries of science to enhance lives globally through reliable, innovative and valuable products. We are committed to fostering an environment that nurtures creativity and innovation while adapting to the dynamic landscape of technology through strategic investments. Our dedication to perfection, quality and cost effectiveness enables us to serve niche markets with agility, all while upholding the highest standards of corporate responsibility, regulatory compliance and environmental stewardship.
Why Tenshi Kaizen
At Tenshi Kaizen, our unique value proposition is defined by the perfect balance of regulatory excellence, scientific innovation and deep client partnership. Every facet of our ecosystem is purpose built to deliver unmatched outcomes for our clients efficiently, reliably and with integrity.
Unmatched Quality & Regulatory Strength
Our state of the art manufacturing facility has consistently met the most stringent global standards. Successfully inspected and approved by leading authorities including the USFDA, EU, TGA and Health Canada, we ensure end-to-end compliance, product safety and global market readiness from day one.
Technology And Driven Innovation
From formulation to packaging, our innovation led cGMP facility ensures precision, flexibility and speed. Instapill disperses in just 3–10 seconds, while automated processes support both gelatin and non-gelatin formulations delivering quality with compliance.
Transparent & Trusted Partnerships
We operate as an extension of our client’s teams with real time collaboration, proactive engagement and seamless communication. Our experienced program management team drives complex projects with agility and discipline creating high trust relationships built on reliability and shared success.
Proven Client Delivery
On-time. In-full. Every time. Our team’s deep technical and operational expertise enables us to consistently deliver across diverse, complex development and manufacturing programs. We tailor every process to meet specific product quality profiles, with clinical outcomes that reinforce our client’s confidence in us.
Core Capabilities
Output Capability
Over 2,000 commercial batches supplied to the US, Canada, Europe and Australia.
- Scalable GMP manufacturing from 10m² Lyo (8-13k tablets) to 4x60m² Lyos (240-360k tablets).
Controls
Fully automatic process from dosing to palletization of finished product.
- Quality Control: Features online check weighers, print and Spectr and security seal applicators.
- Serialisation: Supports commercial production.
- Automation: Integrated line with e-log books and e-batch records.
Capacity
Two facility blocks with capacities of 60 million and 240 million units offering flexibility for judicious manufacturing of clinical and commercial batches with adequate warehousing.
- Expansion: Planned capacity increase to target 300 million units annually. Continuous improvement to enhance efficiency and reduce cycle times.
Our Journey
Tenshi Kaizen began with a vision to revolutionize drug delivery through our proprietary InstaPill® technology platform. Founded in Bengaluru, India, we are a team of highly qualified pharmaceutical professionals focused on developing orally disintegrating tablets that disperse within 3-10 seconds without water. This innovative approach has positioned us as global leaders in this specialized technology with our products now registered and distributed in over 50 countries.
2017
Established the InstaPill® platform marking the start of our innovative drug delivery solutions.
Global Presence
Tenshi Kaizen currently operates a state of the art facility in Bengaluru with a capacity of 200 million ODTs which is set to scale up to 300 million ODTs. This facility serves as the cornerstone of our commitment to delivering high quality, scalable manufacturing solutions.
Our strategic vision includes plans for global expansion in the near term allowing us to extend our reach and support clients in diverse healthcare environments worldwide. While our current operations are centered in Bengaluru, our future growth initiatives will enable us to serve regulated and semi regulated markets with the same level of consistency and compliance.
We collaborate closely with our partners to navigate regulatory pathways and accelerate the delivery of differentiated treatments to market, whether launching new therapies or scaling established brands.
Partner With Us
Tenshi Kaizen has the platform technology and taste masking expertise to bring your Target Product Profile ODT from feasibility to market using QbD principles. Tenshi Kaizen currently operates a state-of-the-art facility in Bengaluru with a capacity of 200 million ODTs which is set to scale up to 300 million ODTs.
Our fully automated, integrated line with serialisation and electronic batch records simplifies your supply chain with the highest quality and regulatory compliance standards. We always invest in capacity well in advance of requirements so you can trust us to be your turnkey CDMO partner for your next patient-centric medicine.